Addressing mental illness with psychedelic-assisted therapy
People affected by mental health disorders are seeking safe and enduring treatments. Improving your mood, outlook, and quality of life is possible with protocols facilitated by our experienced guides that aim to maximize your brain’s neuroplastic potential.
Choosing the path that’s right for you
Clinical Trials or Ketamine-Assisted Psychotherapy
Whether it is ketamine-assisted psychotherapy to tackle deep-rooted mental health conditions, or highly regulated clinical trials with restricted-access medicines to address a specific diagnosis, approved protocols are matched to your needs.
- Major Depression
- Post-Traumatic Stress Disorder (PTSD)
- Anxiety disorders
- End-of-life existential crisis
- Palliative care for disease
- Drug use disorders
- Alcohol use disorders
- Chronic pain
Clinical Trials for Mental Health Disorders
Learn About Our Clinical Trials
If you seeking ketamine-assisted psychotherapy or are interested in a current clinical trial, schedule a consultation with our team.
We serve all California communities.
A team you can trust
A safe, comfortable, and private environment that promotes healing. Supporting you from preparation to the dosing journey and throughout the integration process, our compassionate, experienced, dedicated medical team is here for you.
JAMA | August 2023: Single-Dose Psilocybin Treatment for Major Depressive Disorder – A Randomized Clinical Trial
Importance: Psilocybin shows promise as a treatment for major depressive disorder (MDD).
Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith Heinzerling, Boadie W. Dunlop, Randall T. Brown, Rishi Kakar, Michael Hassman, Rupal P. Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew D. Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie Wilson, Carrie Brown, William Linton, Stephen Ross, Roland R. Griffiths.
Meet Dr. Keith Heinzerling
Dr. Keith Heinzerling is the director of the Pacific Treatment & Research In Psychedelics (TRIP) Center. He is involved in the development of psychedelic-assisted therapies for those suffering with addiction, depression, anxiety, and PTSD. Learn more.
Pacific TRIP Center News, Healthy Living and Education
Embracing the Psychedelic Renaissance: Pacific Neuroscience Institute Unveils New Center of Excellence
We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.
What is Ketamine Therapy?
Ketamine therapy is used to treat of depression, anxiety, PTSD, end-of-life distress, chronic pain, drug/alcohol problems, and more. Learn how it works.
PNI Publishes First-Ever Paper on Psychedelics in Neurosurgery and Neuro-oncology Literature
After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).
Vikki’s Path to Sobriety at the Treatment & Research In Psychedelics (TRIP) Program
After years of unsuccessful therapy, Vikki transformed her life for the better with psychedelic-assisted therapy at PNI’s Pacific Treatment & Research In Psychedelics (TRIP). Learn more about her journey toward healing.